Table I.
MIR31HG expression levels | ||||
---|---|---|---|---|
Clinicopathologic parameters | Patient no. | Lower (n=41) | Higher (47) | P-value |
Age (years) | 0.594 | |||
≤60 | 52 | 23 | 29 | |
>60 | 36 | 18 | 18 | |
Sex | 0.224 | |||
Male | 49 | 20 | 29 | |
Female | 39 | 21 | 18 | |
Tumor size | 0.876 | |||
<3 cm | 48 | 22 | 26 | |
>3 cm | 40 | 19 | 21 | |
Smoking | 0.285 | |||
No | 44 | 23 | 21 | |
Yes | 44 | 18 | 26 | |
Histological differentiation grade | 0.024a | |||
Moderate-well | 32 | 20 | 12 | |
Poorly | 56 | 21 | 35 | |
Histology | 0.294 | |||
SCC | 55 | 28 | 27 | |
AC | 33 | 13 | 20 | |
Lymph node metastasis | 0.021a | |||
Negative | 40 | 24 | 16 | |
Positive | 48 | 17 | 31 | |
TNM stage (12) | 0.002a | |||
I–II | 49 | 30 | 19 | |
III | 39 | 11 | 28 |
TNM, tumor-node-metastasis staging system; SCC, small squamous cell carcinoma; AC, adenocarcinoma.
P<0.05.